Medtronic‘s Physio-Control, Inc. received FDA approval to market the new LIFEPAK 15 portable monitor/defibrillator. The system is equipped with the latest gadgetry like a metronome to aid with compressions during CPR, a high contrast screen for easier outdoor operation, and Masimo’s pulse oximetry.
Here is a more complete list of features:
Noninvasive and continuous detection of carbon monoxide (SpCO), oxygen saturation (SpO2), and methemoglobin (SpMET) through integrated Masimo Rainbow technology. The CPR Metronome with audible prompts has been proven to aid users in performing compressions and ventilations within the recommended range of AHA Guidelines. Energy dosing to 360J for difficult-to-defibrillate patients. Easy to acquire pre-medication 12-lead ECG and reliable, continuous monitoring of all 12 leads in the background to alert you to changes via our ST Trending feature. Large, high quality dual-mode color LCD screen with one touch switching to high-contrast SunVue™ mode for use in bright sunlight Advanced Lithium-ion battery technology to give you up to six hours of operating time-enough juice to run a shift A platform with a new state-of-the-art processor and more memory so the 15 can grow and adapt as your needs change
Company video introducing the device:
Press release: Physio-Control Receives FDA 510(K) Clearance For LIFEPAK® 15 Monitor/Defibrillator…
LIFEPAK 15 product page…
